The global Fecal Immunochemical Diagnostic Test (FIT) market was valued at USD 1.3 billion in 2022 and is projected to surpass USD 2.1 billion by 2031, expanding at a CAGR of 5.7% from 2023 to 2031. Market growth is driven by the increasing prevalence of colorectal cancer, rising awareness of early disease screening, and growing adoption of non-invasive diagnostic tests.
Rise in prevalence of colorectal cancer (CRC) across the globe and increase in demand for non-invasive diagnostic methods are driving the global fecal immunochemical diagnostic test (FIT) market. FIT is considered a highly accurate and convenient method for CRC screening, and its ease of use and patient acceptance have made it a preferred screening method in several countries.
Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=80238
Increase in demand for FIT testing in the next few years is likely to accelerate market development. Furthermore, governments and organizations are promoting CRC screening programs, which is expected to propel the fecal immunochemical diagnostic test (FIT) industry growth.
Development of more sensitive, higher specificity, and low cost fecal immunochemical diagnostic tests offers lucrative opportunities to market players. Companies are focusing on development of technologically advanced fecal immunochemical tests in order to increase market share.
Key Findings of the Market Report
- Kits & Reagents Dominate: High-sensitivity kits and consumable reagents account for approximately 49.5% of total market revenue due to their recurring, high-volume use in routine annual screenings.
- Analyzer Automation: The Benchtop Analyzers segment is expanding at the fastest product-level rate (11.2% CAGR), driven by lab consolidation and the need for standardized, traceable automated workflows.
- Home Care/DTC Disruption: At-home collection and Direct-to-Consumer mail-in screening options are expanding at 12.6%, proving highly popular for overcoming patient reluctance associated with traditional clinical sampling.
- Hospital & Lab Footfall: Combined hospital and commercial diagnostic laboratories continue to handle the lion's share of testing processing, claiming over 42% of end-user market volume in 2026.
Global Market: Growth Drivers
- Rising Global CRC Incidence: Colorectal cancer remains one of the most diagnosed malignancies worldwide, magnifying the global clinical focus on early-stage intervention.
- Cost-Effectiveness vs. Colonoscopy: At roughly US$ 20–$ 40 per kit, FIT represents a highly scalable, economically viable primary screening tier for resource-constrained public health networks compared to invasive endoscopy.
- Favorable Clinical Guidelines: Broad international consensus recommending annual or biennial non-invasive testing for average-risk adults forms a non-discretionary baseline of market demand.
- Frictionless Compliance: The absence of dietary or medication restrictions prior to taking a FIT test ensures significantly higher patient compliance rates over legacy fecal tests.
Global Market: Key Players
The competitive arena features established global in-vitro diagnostics giants alongside specialized diagnostic materials innovators.
- Sysmex Corporation (Major market force with an expanding high-volume stool-testing portfolio and regional distribution partnerships)
- Eiken Chemical Co., Ltd. (Developer of the widely adopted OC-SENSOR technology platform and a pillar in automated FIT analytics)
- Abbott Laboratories (Leading provider of diagnostic instruments and scalable immunoassay systems)
- Sentinel Diagnostics (Sentinel CH. SpA) (Pioneers in high-throughput fecal testing systems, notably the SENTiFIT series)
- QuidelOrtho Corporation (Significant provider of rapid point-of-care assays and laboratory diagnostic equipment)
- Danaher Corporation (Beckman Coulter, Inc.) (Supplying integrated lab clinical analyzers and high-specificity reagents)
- FUJIFILM Corporation (Expanding presence through clinical diagnostics and advanced imaging/testing interfaces)
- Quest Diagnostics Incorporated (Dominant logistics and laboratory processing network driving domestic clinical sample volumes)
- Freenome Holdings, Inc. (Active in multiomics and advanced screening research to push early detection boundaries)
Global Market: Segmentation
By Product Type
- Kits & Reagents: Single-use patient collection systems, rapid lateral flow cassettes, and liquid reagents.
- Analyzers: Fully automated, high-throughput systems and compact benchtop units used for quantitative hemoglobin measurement.
By End-User
- Hospitals & Diagnostic Laboratories: Centralized infrastructure processing high-volume public screening contracts.
- Home Care Settings / Direct-to-Consumer (DTC): Patient-initiated or employer-sponsored at-home screening channels.
- Specialty & Outpatient Clinics: Point-of-care evaluations during routine gastrointestinal or physical exams.
By Test Type
- Quantitative FIT: High-end laboratory-read tests that provide exact hemoglobin concentrations; heavily favored in organized national programs.
- Qualitative FIT: Rapid, visual yes/no diagnostic cassettes designed for immediate point-of-care or OTC clinical assessments.
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=80238<ype=S
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
